ABBOTT LABORATORIES Repayments of Long-Term Debt
ABBOTT LABORATORIES (ABT) reported Repayments of Long-Term Debt of $1.42 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-04-29
- ABBOTT LABORATORIES repayments of long-term debt for the quarter ending 2026-03-31 was $1.42B, a 41.46% increase year-over-year.
- ABBOTT LABORATORIES repayments of long-term debt for the quarter ending 2025-09-30 was $501.00M, a 24950.00% increase year-over-year.
- ABBOTT LABORATORIES repayments of long-term debt for the quarter ending 2025-06-30 was $1.00M, a 94.44% decline year-over-year.
- ABBOTT LABORATORIES repayments of long-term debt for the quarter ending 2025-03-31 was $1.00B.
- ABBOTT LABORATORIES repayments of long-term debt for fiscal 2021 was $48.00M, a 96.40% decline from fiscal 2020.
- ABBOTT LABORATORIES repayments of long-term debt for fiscal 2020 was $1.33B, a 61.26% decline from fiscal 2019.
- ABBOTT LABORATORIES repayments of long-term debt for fiscal 2019 was $3.44B, a 72.32% decline from fiscal 2018.
- ABBOTT LABORATORIES repayments of long-term debt for fiscal 2018 was $12.43B, a 43.73% increase from fiscal 2017.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $1.42B 10-Q · filed 2026-04-29 | ||||
| 2025-09-30 | $501.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $502.00M derived: sum of 2 quarters · filed 2025-10-29 | $1.50B 10-Q · filed 2025-10-29 | ||
| 2025-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $1.00B 10-Q · filed 2025-07-30 | |||
| 2025-03-31 | $1.00B 10-Q · filed 2026-04-29 | ||||
| 2024-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $20.00M derived: sum of 2 quarters · filed 2025-10-29 | $20.00M 10-Q · filed 2025-10-29 | ||
| 2024-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $18.00M 10-Q · filed 2025-07-30 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-04-30 | ||||
| 2023-09-30 | $1.45B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.45B derived: sum of 2 quarters · filed 2024-10-31 | $1.45B 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $2.00M 10-Q · filed 2024-07-31 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | ||||
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $2.00M derived: sum of 2 quarters · filed 2023-11-01 | $753.00M 10-Q · filed 2023-11-01 | $756.00M derived: sum of 4 quarters · filed 2023-11-01 | |
| 2022-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $752.00M 10-Q · filed 2023-08-03 | $755.00M derived: sum of 3 quarters · filed 2023-08-03 | $795.00M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $751.00M 10-Q · filed 2023-05-04 | $754.00M derived: sum of 2 quarters · filed 2023-05-04 | $794.00M derived: sum of 3 quarters · filed 2023-05-04 | $797.00M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $43.00M derived: sum of 2 quarters · filed 2022-11-01 | $46.00M derived: sum of 3 quarters · filed 2022-11-01 | $48.00M 10-K · filed 2022-02-18 | |
| 2021-09-30 | $40.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $43.00M derived: sum of 2 quarters · filed 2022-11-01 | $45.00M 10-Q · filed 2022-11-01 | $46.00M derived: sum of 4 quarters · filed 2022-11-01 | |
| 2021-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $5.00M 10-Q · filed 2022-08-02 | $6.00M derived: sum of 3 quarters · filed 2022-08-02 | $1.34B derived: sum of 4 quarters · filed 2022-08-02 | |
| 2021-03-31 | $2.00M 10-Q · filed 2022-05-03 | $3.00M derived: sum of 2 quarters · filed 2022-05-03 | $1.33B derived: sum of 3 quarters · filed 2022-05-03 | $1.33B derived: sum of 4 quarters · filed 2022-05-03 | |
| 2020-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $1.33B derived: sum of 2 quarters · filed 2022-02-18 | $1.33B derived: sum of 3 quarters · filed 2022-02-18 | $1.33B 10-K · filed 2022-02-18 | |
| 2020-09-30 | $1.33B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $1.33B derived: sum of 2 quarters · filed 2021-11-03 | $1.33B 10-Q · filed 2021-11-03 | $4.25B derived: sum of 4 quarters · filed 2022-02-18 | |
| 2020-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.00M 10-Q · filed 2021-08-04 | $2.92B derived: sum of 3 quarters · filed 2022-02-18 | $2.92B derived: sum of 4 quarters · filed 2022-02-18 | |
| 2020-03-31 | $1.00M 10-Q · filed 2021-05-05 | $2.92B derived: sum of 2 quarters · filed 2022-02-18 | $2.92B derived: sum of 3 quarters · filed 2022-02-18 | $2.94B derived: sum of 4 quarters · filed 2022-02-18 | |
| 2019-12-31 | $2.92B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $2.92B derived: sum of 2 quarters · filed 2022-02-18 | $2.94B derived: sum of 3 quarters · filed 2022-02-18 | $3.44B 10-K · filed 2022-02-18 | |
| 2019-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $23.00M derived: sum of 2 quarters · filed 2020-11-04 | $523.00M 10-Q · filed 2020-11-04 | $4.68B derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $521.00M 10-Q · filed 2020-07-29 | $4.67B derived: sum of 3 quarters · filed 2021-02-19 | $5.67B derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-03-31 | $500.00M 10-Q · filed 2020-04-29 | $4.65B derived: sum of 2 quarters · filed 2021-02-19 | $5.65B derived: sum of 3 quarters · filed 2021-02-19 | $6.95B derived: sum of 4 quarters · filed 2021-02-19 | |
| 2018-12-31 | $4.15B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $5.15B derived: sum of 2 quarters · filed 2021-02-19 | $6.45B derived: sum of 3 quarters · filed 2021-02-19 | $12.43B 10-K · filed 2021-02-19 | |
| 2018-09-30 | $999.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.30B derived: sum of 2 quarters · filed 2019-10-31 | $8.28B 10-Q · filed 2019-10-31 | $14.42B derived: sum of 4 quarters · filed 2020-02-21 | |
| 2018-06-30 | $1.30B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $7.28B 10-Q · filed 2019-07-31 | $13.42B derived: sum of 3 quarters · filed 2020-02-21 | $13.42B derived: sum of 4 quarters · filed 2020-02-21 | |
| 2018-03-31 | $5.98B 10-Q · filed 2019-05-01 | $12.12B derived: sum of 2 quarters · filed 2020-02-21 | $12.12B derived: sum of 3 quarters · filed 2020-02-21 | $12.12B derived: sum of 4 quarters · filed 2020-02-21 | |
| 2017-12-31 | $6.14B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $6.14B derived: sum of 2 quarters · filed 2020-02-21 | $6.14B derived: sum of 3 quarters · filed 2020-02-21 | $8.65B 10-K · filed 2020-02-21 | |
| 2017-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $3.00M derived: sum of 2 quarters · filed 2018-10-31 | $2.51B 10-Q · filed 2018-10-31 | $2.51B derived: sum of 4 quarters · filed 2019-02-22 | |
| 2017-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $2.51B 10-Q · filed 2018-08-01 | $2.51B derived: sum of 3 quarters · filed 2019-02-22 | $2.51B derived: sum of 4 quarters · filed 2019-02-22 | |
| 2017-03-31 | $2.50B 10-Q · filed 2018-05-02 | $2.51B derived: sum of 2 quarters · filed 2019-02-22 | $2.51B derived: sum of 3 quarters · filed 2019-02-22 | $2.51B derived: sum of 4 quarters · filed 2019-02-22 | |
| 2016-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $2.00M derived: sum of 2 quarters · filed 2019-02-22 | $5.00M derived: sum of 3 quarters · filed 2019-02-22 | $12.00M 10-K · filed 2019-02-22 | |
| 2016-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $4.00M derived: sum of 2 quarters · filed 2017-11-02 | $11.00M 10-Q · filed 2017-11-02 | $32.00M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2016-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $10.00M 10-Q · filed 2017-08-02 | $31.00M derived: sum of 3 quarters · filed 2018-02-16 | $34.00M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2016-03-31 | $7.00M 10-Q · filed 2017-05-03 | $28.00M derived: sum of 2 quarters · filed 2018-02-16 | $31.00M derived: sum of 3 quarters · filed 2018-02-16 | $54.00M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2015-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $24.00M derived: sum of 2 quarters · filed 2018-02-16 | $47.00M derived: sum of 3 quarters · filed 2018-02-16 | $57.00M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $26.00M derived: sum of 2 quarters · filed 2016-11-03 | $36.00M 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $33.00M 10-Q · filed 2016-08-03 | |||
| 2015-03-31 | $10.00M 10-Q · filed 2016-05-04 | ||||
| 2014-12-31 | $577.00M 10-K · filed 2017-02-17 | ||||
| 2013-12-31 | $303.00M 10-K · filed 2016-02-19 | ||||
| 2012-12-31 | $11.02B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $11.02B derived: sum of 2 quarters · filed 2015-02-27 | $11.02B derived: sum of 3 quarters · filed 2015-02-27 | $11.07B 10-K · filed 2015-02-27 | $11.07B 10-K · filed 2013-02-15 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $54.00M 10-Q · filed 2013-11-07 | $1.06B derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $54.00M 10-Q · filed 2013-08-06 | $1.06B derived: sum of 3 quarters · filed 2014-02-21 | $1.06B derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-03-31 | $54.00M 10-Q · filed 2013-05-08 | $1.06B derived: sum of 2 quarters · filed 2014-02-21 | $1.06B derived: sum of 3 quarters · filed 2014-02-21 | $2.57B derived: sum of 4 quarters · filed 2014-02-21 | |
| 2011-12-31 | $1.00B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $1.01B derived: sum of 2 quarters · filed 2014-02-21 | $2.51B derived: sum of 3 quarters · filed 2014-02-21 | $3.01B 10-K · filed 2014-02-21 | $3.01B 10-K · filed 2012-02-21 |
| 2011-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $1.51B derived: sum of 2 quarters · filed 2012-11-07 | $2.01B 10-Q · filed 2012-11-07 | $3.68B derived: sum of 4 quarters · filed 2013-02-15 | |
| 2011-06-30 | $1.51B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $2.01B 10-Q · filed 2012-08-07 | $3.68B derived: sum of 3 quarters · filed 2013-02-15 | $3.68B derived: sum of 4 quarters · filed 2013-02-15 | |
| 2011-03-31 | $500.58M 10-Q · filed 2012-05-08 | $2.17B derived: sum of 2 quarters · filed 2013-02-15 | $2.17B derived: sum of 3 quarters · filed 2013-02-15 | $2.17B derived: sum of 4 quarters · filed 2013-02-15 | |
| 2010-12-31 | $1.67B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $1.67B derived: sum of 2 quarters · filed 2013-02-15 | $1.67B derived: sum of 3 quarters · filed 2013-02-15 | $1.67B 10-K · filed 2013-02-15 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $0.00 derived: sum of 2 quarters · filed 2011-11-04 | $1.25M 10-Q · filed 2011-11-04 | $1.25M derived: sum of 4 quarters · filed 2012-02-21 | |
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $1.25M 10-Q · filed 2011-08-04 | $1.25M derived: sum of 3 quarters · filed 2012-02-21 | $1.25M derived: sum of 4 quarters · filed 2012-02-21 | |
| 2010-03-31 | $1.25M 10-Q · filed 2011-05-06 | $1.25M derived: sum of 2 quarters · filed 2012-02-21 | $1.25M derived: sum of 3 quarters · filed 2012-02-21 | $501.25M derived: sum of 4 quarters · filed 2012-02-21 | |
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $0.00 derived: sum of 2 quarters · filed 2012-02-21 | $500.00M derived: sum of 3 quarters · filed 2012-02-21 | $2.48B 10-K · filed 2012-02-21 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $500.00M derived: sum of 2 quarters · filed 2010-11-05 | $2.48B 10-Q · filed 2010-11-05 | $3.00B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-06-30 | $500.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $2.48B 10-Q · filed 2010-08-05 | $3.00B derived: sum of 3 quarters · filed 2011-02-18 | $3.20B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-03-31 | $1.98B 10-Q · filed 2010-05-04 | $2.50B derived: sum of 2 quarters · filed 2011-02-18 | $2.70B derived: sum of 3 quarters · filed 2011-02-18 | ||
| 2008-12-31 | $513.95M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $713.95M derived: sum of 2 quarters · filed 2011-02-18 | $913.95M 10-K · filed 2011-02-18 | ||
| 2008-09-30 | $200.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | $400.00M 10-Q · filed 2009-11-06 | |||
| 2008-06-30 | $200.00M 10-Q · filed 2009-08-07 | ||||
| 2007-12-31 | $441.01M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |